Results, Reports & Presentations

Oncimmune Holdings PLC was admitted to trading on the Alternative Investment Market (“AIM”) of the London Stock Exchange on Wednesday 18th May 2016. When the Company publishes financial reports, in keeping with its regulatory obligations, these documents will be available here.

Results
DATE TITLE TYPE
October 31 Annual Results 2018
For the half year ended 31 May 2018
Interim Results
February 13 Interim Results 2017
For the half year ended 30 November 2017
Interim Results
October 20 Annual Results 2017
For the full year ended 31 May 2017
Annual Results 2017
February 10 Interim Results 2016
For the half year ended 30 November 2016
Interim Results
November 7 Annual Results 2016
For the year ended 31 May 2016
Annual Report
Reports
Date Title TYPE
November 5 Annual Report 2018
For the year ended 31 May 2018
Annual Report 2018
November 3 Annual Report 2017
For the year ended 31 May 2017
Annual Report 2017
November 7 Annual Report 2016
For the year ended 31 May 2016
Annual Report 2016
Presentations
DATE TITLE TYPE
October 31 Annual Results Presentation 2018
For the year ended 31 May 2018
Annual Results Presentation
February 13 Interim Results Presentation 2017
For the half year ended 30 November 2017
Interim Results Presentation
October 20 Annual Results Presentation 2017
For the year ended 31 May 2017
Annual Results Presentation
February 10 Interim Results Presentation 2016
For the half year ended 30 November 2016
Interim Results Presentation
November 7 Annual Results Presentation 2016
For the half year ended 30 November 2017
Annual Results Presentation